NCT02764346

Brief Summary

This study will look at the use and impact of smartphone application (app) for adolescents with ongoing pain caused by their juvenile idiopathic arthritis (JIA).The current project will include three studies. First, the investigators conducted usability sessions with adolescents with JIA to refine the app so that it is usable, acceptable and understandable. The aim of this study is to look at (a) how regularly the "iCanCope with Pain" app is used and (b) any effect the app has on young people's health. This study will compare two groups of young people: one that is using the new app, and one that receives usual medical care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 27, 2016

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 6, 2016

Completed
2 months until next milestone

Study Start

First participant enrolled

July 1, 2016

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

April 20, 2020

Status Verified

April 1, 2020

Enrollment Period

3.4 years

First QC Date

April 27, 2016

Last Update Submit

April 17, 2020

Conditions

Keywords

ArthritisSelf-managementPain

Outcome Measures

Primary Outcomes (8)

  • Participant accrual rate

    Centrally tracked by the clinical research project coordinator

    8 weeks

  • Number of issues or difficulties in implementing the intervention

    The intervention fidelity log will track any issues or difficulties encountered during implementation of the intervention, control strategy, or outcome measures will be tracked throughout the study by the CRPC.

    8 weeks

  • Acceptability of intervention

    Participants in the intervention arm will complete the Acceptability e-scale (AES) post-intervention. In addition, a subset of participants from the intervention group will be offered to participate in a qualitative feedback interview to further explore acceptability of the intervention.

    8 weeks

  • Frequency of login per user

    Measured through the iCanCope server.

    8 weeks

  • Adherence

    Adherence will be determined using Google Analytics.

    8 weeks

  • Adverse Events

    Adverse events will be tracked using an adverse event form

    8 weeks

  • Participant dropout rate

    Centrally tracked by clinical research project coordinator

    8 weeks

  • Satisfaction of intervention

    A subset of participants from the intervention group will be offered to participate in a qualitative feedback interview to further explore satisfaction of the intervention.

    8 weeks

Secondary Outcomes (6)

  • Pain

    8 weeks

  • Pain-Related Activity Limitations

    8 weeks

  • Pain coping

    8 weeks

  • Health-Related Quality of Life (HRQoL)

    8 weeks

  • Health care utilization form

    8 weeks

  • +1 more secondary outcomes

Study Arms (2)

iCanCope app

EXPERIMENTAL

iCanCope app

Behavioral: iCanCope app

Attention control app

ACTIVE COMPARATOR

Control group: iCanCope attention control app

Behavioral: iCanCope attention control app

Interventions

iCanCope appBEHAVIORAL

In addition to standard medical care, adolescents in the experimental group will receive access to the "iCanCope" smartphone app for 8 weeks. The app consists of daily pain symptom tracking (pain intensity, sleep, mood, physical activity, and fatigue), goal setting, in-the moment coping strategies, as well as a social community component.

iCanCope app

The control group is designed to control for the potential effects on outcomes of time, attention, and smartphone use during the intervention. In addition to standard medical care, adolescents in the attention control group will receive access to the "iCanCope" control app, with limited functionality.

Attention control app

Eligibility Criteria

Age12 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Aged 12-18 years
  • Diagnosed with JIA (36) as per their rheumatologist
  • Able to speak and read English
  • Have self-reported average arthritis-related pain in the past week of \>3 on 10cm visual analogue scale (VAS)
  • Willing to complete online study outcome measures

You may not qualify if:

  • Moderate to severe cognitive impairments as per their healthcare provider
  • Major co-morbid psychiatric \[conversion disorder, depression, anxiety disorder\] illnesses that may impact their ability to understand and use the "iCanCope with Pain" intervention as per their rheumatologist
  • Received more than 4 CBT sessions for pain management in the past 6 months, as per their healthcare provider and self-report
  • Patients from the department of haematology/oncology

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Hospital for Sick Children

Toronto, Ontario, M5G1X8, Canada

Location

Related Publications (1)

  • Lalloo C, Harris LR, Hundert AS, Berard R, Cafazzo J, Connelly M, Feldman BM, Houghton K, Huber A, Laxer RM, Luca N, Schmeling H, Spiegel L, Tucker LB, Pham Q, Davies-Chalmers CC, Stinson JN. The iCanCope pain self-management application for adolescents with juvenile idiopathic arthritis: a pilot randomized controlled trial. Rheumatology (Oxford). 2021 Jan 5;60(1):196-206. doi: 10.1093/rheumatology/keaa178.

MeSH Terms

Conditions

Arthritis, JuvenileArthritisPain

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal DiseasesRheumatic DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinician Scientist, Clinical Nurse Specialist/NP

Study Record Dates

First Submitted

April 27, 2016

First Posted

May 6, 2016

Study Start

July 1, 2016

Primary Completion

December 1, 2019

Study Completion

December 1, 2019

Last Updated

April 20, 2020

Record last verified: 2020-04

Locations